Exchange: NASDAQ·Updated 07:30 PM EST

ERAS News

News
all
press releases
Erasca, Inc. (NASDAQ:ERAS) Stock Has Consensus Price Target of $23.17 According to Analysts
Erasca, Inc. (NASDAQ:ERAS - Get Free Report) has received an average rating of "Moderate Buy" from the twelve brokerages that are presently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation...
MarketBeat
Erasca, Inc. (NASDAQ:ERAS) Stock Has Consensus Price Target of $23.17 According to Analysts
Erasca, Inc. (NASDAQ:ERAS - Get Free Report) has received an average rating of "Moderate Buy" from the twelve brokerages that are presently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation...
MarketBeat
More News
Erasca, Inc. (ERAS) Discusses Phase I Efficacy and Safety Data for Pan-RAS Molecular Glue ERAS-0015 Transcript...
SeekingAlpha
Erasca (NASDAQ:ERAS) Shares Gap Down - Here's What Happened...
MarketBeat
Erasca: 'Buy' On Expanded KRAS Targeting ERAS-4001 And Bristol-Myers Squibb Collaboration Tie-Up...
SeekingAlpha
Erasca reports strong Phase 1 tumor responses for ERAS-0015 and ERAS-4001 and accelerates its Phase 3 pancreatic cancer trial to early 2027.read more...
Benzinga
Erasca (NASDAQ:ERAS) Stock Price Up 5.4% - Should You Buy...
MarketBeat
Erasca (NASDAQ:ERAS) Stock Price Breaks Below 50 Day Moving Average - Here's What Happened...
MarketBeat
Leerink Partners assumed coverage on shares of Erasca in a research report on Tuesday. They issued an "outperform" rating and a $35.00 target price on the stock...
MarketBeat
Erasca, Inc. (NASDAQ:ERAS - Free Report) - Equities researchers at HC Wainwright dropped their FY2026 earnings estimates for Erasca in a research report issued to clients and investors on Friday, November 13th. HC Wainwright analyst A. Maldonado now forecasts that the company will post earnings of...
MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERASPR NewswireNEW YORK, Nov. 5, 2026 NEW YORK, Nov. 5, 2026 /PRNewswire/ -- Pomerantz LLP is...
PR Newswire

Advertisement|Remove ads.